These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48 related articles for article (PubMed ID: 13123970)
1. The mechanism of the irreversible inhibition of cholinesterase by the alkyl phosphate esters. MYERS DK Acta Physiol Pharmacol Neerl; 1953; 3(1):136-8. PubMed ID: 13123970 [No Abstract] [Full Text] [Related]
2. [The mechanism of the interrelationship between cholinesterase and irreversible organic phosphate inhibitors in the presence of substrates]. Volkova RI Biokhimiia; 1965; 30(2):292-301. PubMed ID: 5883876 [No Abstract] [Full Text] [Related]
7. [Poisoning by irreversible cholinesterase inhibitors; cholinesterase reactivators as antidotes]. BARSTAD JA Tidsskr Nor Laegeforen; 1959 Apr; 79(8):464-70. PubMed ID: 13659490 [No Abstract] [Full Text] [Related]
8. [Behavior of the anticholinesterase action of phosphoric esters in the rat under various experimental conditions. I. Intoxication associated with a dimethyl and an ethyl phosphate]. SALVINI M; TOMINZ L; GAZZANIGA P Boll Soc Ital Biol Sper; 1961 Jul; 37():658-61. PubMed ID: 13745834 [No Abstract] [Full Text] [Related]
9. Synthesis of organophosphates with fluorine-containing leaving groups as serine esterase inhibitors with potential for Alzheimer disease therapeutics. Makhaeva GF; Aksinenko AY; Sokolov VB; Serebryakova OG; Richardson RJ Bioorg Med Chem Lett; 2009 Oct; 19(19):5528-30. PubMed ID: 19717305 [TBL] [Abstract][Full Text] [Related]
10. 3-Fluoro-2,4-dioxa-3-phosphadecalins as inhibitors of acetylcholinesterase. A reappraisal of kinetic mechanisms and diagnostic methods. Baici A; Schenker P; Wächter M; Rüedi P Chem Biodivers; 2009 Mar; 6(3):261-82. PubMed ID: 19319863 [TBL] [Abstract][Full Text] [Related]
11. Cholinesterase from the common prawn (Palaemon serratus) eyes: catalytic properties and sensitivity to organophosphate and carbamate compounds. Frasco MF; Fournier D; Carvalho F; Guilhermino L Aquat Toxicol; 2006 May; 77(4):412-21. PubMed ID: 16497396 [TBL] [Abstract][Full Text] [Related]
12. [Comparative analysis of sensitivity of proteases (chymotrypsin and trypsin) and cholinesterases of different origin to some organophosphorus inhibitors]. Rozengart EV Zh Evol Biokhim Fiziol; 2009; 45(3):277-83. PubMed ID: 19569552 [TBL] [Abstract][Full Text] [Related]
13. Cholinesterase inhibition: is there evidence for disease-modifying effects? Shanks M; Kivipelto M; Bullock R; Lane R Curr Med Res Opin; 2009 Oct; 25(10):2439-46. PubMed ID: 19678754 [TBL] [Abstract][Full Text] [Related]
14. Structure-activity relationships for inhibition of human cholinesterases by alkyl amide phenothiazine derivatives. Darvesh S; McDonald RS; Penwell A; Conrad S; Darvesh KV; Mataija D; Gomez G; Caines A; Walsh R; Martin E Bioorg Med Chem; 2005 Jan; 13(1):211-22. PubMed ID: 15582466 [TBL] [Abstract][Full Text] [Related]
15. Mechanisms of cholinesterase inhibition by inorganic mercury. Frasco MF; Colletier JP; Weik M; Carvalho F; Guilhermino L; Stojan J; Fournier D FEBS J; 2007 Apr; 274(7):1849-61. PubMed ID: 17355286 [TBL] [Abstract][Full Text] [Related]
16. Novel carbamate cholinesterase inhibitors that release biologically active amines following enzyme inhibition. Verheijen JC; Wiig KA; Du S; Connors SL; Martin AN; Ferreira JP; Slepnev VI; Kochendörfer U Bioorg Med Chem Lett; 2009 Jun; 19(12):3243-6. PubMed ID: 19423342 [TBL] [Abstract][Full Text] [Related]
17. Use of benchmark dose and meta-analysis to determine the most sensitive endpoint for risk assessment for dimethoate. Reiss R; Gaylor D Regul Toxicol Pharmacol; 2005 Oct; 43(1):55-65. PubMed ID: 16099569 [TBL] [Abstract][Full Text] [Related]
18. Dialkyl phenyl phosphates as novel selective inhibitors of butyrylcholinesterase. Law KS; Acey RA; Smith CR; Benton DA; Soroushian S; Eckenrod B; Stedman R; Kantardjieff KA; Nakayama K Biochem Biophys Res Commun; 2007 Apr; 355(2):371-8. PubMed ID: 17307152 [TBL] [Abstract][Full Text] [Related]
19. [Finding cholinesterase in endotheliocytes: cholinesterase inhibition by organophosphorus compounds leads to endotheliocyte deformation]. Prozorovskiĭ VB; Skopichev VG Eksp Klin Farmakol; 2005; 68(3):64-7. PubMed ID: 16047685 [TBL] [Abstract][Full Text] [Related]